Receptor, Biochemistry, Cell biology, Nuclear receptor and Protein structure are his primary areas of study. H. Eric Xu has researched Receptor in several fields, including Small molecule and Binding site. He focuses mostly in the field of Biochemistry, narrowing it down to matters related to Biophysics and, in some cases, Peptide sequence.
In the subject of general Cell biology, his work in Signal transduction and Arrestin is often linked to Rhodopsin, thereby combining diverse domains of study. The Nuclear receptor study combines topics in areas such as Coactivator, CYP27A1 and Cytochrome P450. His Protein structure research is multidisciplinary, incorporating elements of Plasma protein binding and Cellular differentiation.
His primary areas of study are Receptor, Biochemistry, Cell biology, G protein-coupled receptor and Signal transduction. His Receptor research integrates issues from Nuclear receptor and Drug discovery. His study in Nuclear receptor is interdisciplinary in nature, drawing from both Coactivator and Peroxisome proliferator-activated receptor.
His study in Biochemistry concentrates on Binding site, Abscisic acid, Protein structure, Phosphatase and Kinase. His research investigates the connection between Cell biology and topics such as Repressor that intersect with problems in Ubiquitin ligase. His Arrestin study in the realm of G protein-coupled receptor interacts with subjects such as Rhodopsin.
His main research concerns G protein-coupled receptor, Receptor, Cell biology, Ligand and Agonist. His G protein-coupled receptor study combines topics from a wide range of disciplines, such as Computational biology, Ion channel, G protein and Cell Surface Display Techniques. His Receptor research incorporates elements of Signal transduction, Central nervous system and Binding site.
H. Eric Xu interconnects Transmembrane domain, Inhibitory postsynaptic potential, Neurotransmission and Peptide in the investigation of issues within Cell biology. In his study, Fentanyl and Arrestin is inextricably linked to Neuroscience, which falls within the broad field of Agonist. A large part of his Biochemistry studies is devoted to Allosteric regulation.
The scientist’s investigation covers issues in G protein-coupled receptor, Receptor, G protein, Cell biology and Computational biology. The G protein-coupled receptor study combines topics in areas such as Agonist, Plasma protein binding and Neuroscience. The concepts of his Receptor study are interwoven with issues in Conserved sequence and Binding site.
As a member of one scientific family, H. Eric Xu mostly works in the field of Binding site, focusing on Ligand and, on occasion, Docking and Signal transduction. His G protein study combines topics in areas such as Arrestin, Structural biology, Fentanyl and Opioid. His Cell biology study combines topics from a wide range of disciplines, such as Methylation, Histone, Adenylate kinase, Linker DNA and Peptide.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport
William R. Oliver;Jennifer L. Shenk;Mike R. Snaith;Caroline S. Russell.
Proceedings of the National Academy of Sciences of the United States of America (2001)
Molecular Recognition of Fatty Acids by Peroxisome Proliferator–Activated Receptors
H.Eric Xu;Millard H Lambert;Valerie G Montana;Derek J Parks.
Molecular Cell (2000)
Crystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Reveals a Novel Mode of Receptor Dimerization and Coactivator Recognition
Randy K. Bledsoe;Valerie G. Montana;Thomas B. Stanley;Chris J. Delves.
Cell (2002)
Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARα
H. Eric Xu;Thomas B. Stanley;Valerie G. Montana;Millard H. Lambert.
Nature (2002)
Asymmetry in the PPARγ/RXRα Crystal Structure Reveals the Molecular Basis of Heterodimerization among Nuclear Receptors
Robert T. Gampe;Valerie G. Montana;Millard H. Lambert;Aaron B. Miller.
Molecular Cell (2000)
Structural Features for Functional Selectivity at Serotonin Receptors
Daniel Wacker;Chong Wang;Vsevolod Katritch;Gye Won Han.
Science (2013)
A gate–latch–lock mechanism for hormone signalling by abscisic acid receptors
Karsten Melcher;Ley-Moy Ng;Ley-Moy Ng;X. Edward Zhou;Fen-Fen Soon;Fen-Fen Soon.
Nature (2009)
Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser
Yanyong Kang;X. Edward Zhou;Xiang Gao;Yuanzheng He.
Nature (2015)
DWARF 53 acts as a repressor of strigolactone signalling in rice
Liang Jiang;Xue Liu;Guosheng Xiong;Huihui Liu.
Nature (2013)
Peroxisome proliferator-activated receptors: from genes to physiology.
Steven A. Kliewer;H. Eric Xu;Millard H. Lambert;Timothy M. Willson.
Recent Progress in Hormone Research (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Van Andel Institute
Chinese Academy of Sciences
Chinese Academy of Sciences
Research Triangle Park Foundation
The University of Texas Southwestern Medical Center
Chinese Academy of Sciences
University of North Carolina at Chapel Hill
Mayo Clinic
Scripps Research Institute
The University of Texas Southwestern Medical Center
Graz University of Technology
McGill University
University of Michigan–Ann Arbor
FX Palo Alto Laboratory
Soochow University
University of Alabama at Birmingham
Madurai Kamaraj University
University of Tennessee Medical Center
Yale University
Brown University
Trinity College Dublin
University of Maryland, Baltimore
University of California, San Diego
Mayo Clinic
National Institutes of Health
University of Washington